The classical NFkappaB pathway is required for phloroglucinol-induced activation of murine lymphocytes

Biochim Biophys Acta. 2010 Jul;1800(7):639-45. doi: 10.1016/j.bbagen.2010.03.014. Epub 2010 Mar 27.

Abstract

Background: Phloroglucinol (PG), a polyphenolic compound, has been proposed to show free radical scavenging, anti-tumor, and immunomodulation effects on immune cells. In this study, we investigated PG for its immunological activity and their molecular mechanisms, specifically focusing on the functional activation of nuclear factor-kappaB (NFkappaB), an important transcription factor involved in the activation and differentiation of lymphocytes, and subsequent recruitment of murine lymphocytes.

Methods: We tested whether PG may contribute to the activation of immune response through the NFkappaB pathway by (3)H-thymidine incorporation assay, Western blot, intracellular cytokine assays and Electrophoretic mobility shift assay (EMSA) in murine lymphocytes.

Results: PG markedly enhanced the proliferation of lymphocytes by inducing the degradation and phosphorylation of IkappaB, which leads to the activation of NFkappaB p65. Also, PG induced the activation of mitogen-activated protein kinases (MAPKs) such as ERK1/2, JNK, and p38, upstream molecules of NFkappaB pathway. In addition, PG augmented the secretion of interleukin (IL)-2 in mature T lymphocytes and their production of IL-2. Furthermore, the application of TPCK significantly reduced the activation of lymphocytes by PG via inhibiting the NFkappaB activation.

Conclusion: These results suggest that PG induces the activation of lymphocytes by inducing the proliferative activity and secretion of IL-2 through the classical NFkappaB.

General significance: The effect of PG on lymphocyte activation was assayed for the first time. These results would also elucidate its underlying mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Cell Survival / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • Interleukin-2 / biosynthesis
  • Lymphocyte Activation / drug effects*
  • Lymphocytes / cytology
  • Lymphocytes / drug effects
  • Lymphocytes / physiology*
  • Mice
  • Mice, Inbred ICR
  • NF-kappa B / physiology*
  • Phloroglucinol / pharmacology*
  • Spleen / cytology
  • Spleen / physiology
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / physiology
  • Thymidine / metabolism
  • Tosylphenylalanyl Chloromethyl Ketone / pharmacology

Substances

  • Cysteine Proteinase Inhibitors
  • Interleukin-2
  • NF-kappa B
  • Tosylphenylalanyl Chloromethyl Ketone
  • Phloroglucinol
  • Thymidine